Atlas Trials

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Clinical trial NCT00632385 · COMPLETED

Trial details

NCT number
NCT00632385
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Migraine
Start date
2003-01-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.